ETON: Eton Pharmaceuticals, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 451.61
Enterprise Value ($M) 464.18
Book Value ($M) 24.45
Book Value / Share 0.91
Price / Book 18.47
NCAV ($M) -9.62
NCAV / Share -0.36
Price / NCAV -46.93

Profitability (mra)
Return on Invested Capital (ROIC) -0.08
Return on Assets (ROA) -0.15
Return on Equity (ROE) -0.30

Liquidity (mrq)
Quick Ratio 1.43
Current Ratio 1.97

Balance Sheet (mrq) ($M)
Current Assets 49.96
Assets 84.03
Liabilities 59.58
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 39.01
Operating Income -2.18
Net Income -3.82
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.97
Cash from Investing -40.01
Cash from Financing 32.59

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-14 13G/A EcoR1 Capital, LLC 7.70 41.74
09-12 13G/A Opaleye Management Inc. 10.34 5.85

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-05-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2025-03-18 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-06-06 67,843 381,787 17.77
2025-06-05 59,390 392,301 15.14
2025-06-04 62,892 482,521 13.03
2025-06-03 236,551 885,127 26.73
2025-06-02 87,099 355,523 24.50

(click for more detail)

Similar Companies
EOLS – Evolus, Inc. ESPR – Esperion Therapeutics, Inc.
ETNB – 89bio, Inc. FATE – Fate Therapeutics, Inc.
FHTX – Foghorn Therapeutics Inc.


Financial data and stock pages provided by
Fintel.io